Cutler Group LP Acumen Pharmaceuticals, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$1.86 - $4.48 $2,418 - $5,824	-1,300 Reduced 52.0%	1,200 $4,000
Q3 2023 Nov 07, 2023	BUY	$4.15 - $9.72 $4,482 - $10,497	1,080 Added 76.06%	2,500 $10,000
Q1 2023 May 01, 2023	SELL	$3.75 - $6.65 $6,296 - $11,165	-1,679 Reduced 54.18%	1,420 $5,000
Q4 2022 Feb 07, 2023	BUY	$4.81 - $10.17 $14,906 - $31,516	3,099 New	3,099 $16,000

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.5M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.